Zobrazeno 1 - 9
of 9
pro vyhledávání: '"patients with alzheimer"'
Publikováno v:
Ankara Medical Journal, Vol 18, Iss 4, Pp 601-611 (2018)
Amaç: Bu araştırma Alzheimer tanılı hastaya ev ortamında bakım veren bireylerin hastalarıyla ilgili yakındıkları hastalık semptomlarını belirlemek amacıyla yapılmıştır. Materyal ve Metot: Tanımlayıcı tipte olan araştırma Alzhe
Externí odkaz:
https://doaj.org/article/6082bdd0ca174fcda154b4a7b257b657
Autor:
Ozlem Mutlu-Burnaz, Burak Yulug, Muhammed Yunus Bektay, Zubeyir Bayraktaroglu, Halil Aziz Velioglu, Guven Toprak, Lutfu Hanoglu, Eray Metin Guler
Publikováno v:
Neurobiology of learning and memory. 180
Repetitive Transcranial Magnetic Stimulation (rTMS) is a non-invasive neuromodulation technique which is increasingly used for cognitive impairment in Alzheimer?s Disease (AD). Although rTMS has been shown to modify Brain-Derived Neurotrophic Factor
Publikováno v:
Ankara Medical Journal, Vol 18, Iss 4, Pp 601-611 (2018)
Volume: 18, Issue: 4 601-611
Ankara Medical Journal
Volume: 18, Issue: 4 601-611
Ankara Medical Journal
Amaç: Bu araştırma Alzheimer tanılı hastaya evortamında bakım veren bireylerin hastalarıyla ilgili yakındıkları hastalıksemptomlarını belirlemek amacıyla yapılmıştır. Materyalve Metot: Tanımlayıcı tipte olan araştırma Alzheime
Orthostatic hypotension (OH) is reported to be more prevalent particularly in patients with Dementia with Lewy bodies (DLB) because of the autonomic dysfunction, but prevalence of OH is not known in patients with Alzheimer Disease (AD). The aim of th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21319c8d3e75112629a5d4cc73de9adf
https://arro.anglia.ac.uk/id/eprint/704392/6/Smith_2019_19.pdf
https://arro.anglia.ac.uk/id/eprint/704392/6/Smith_2019_19.pdf
Publikováno v:
The journal of nutrition, health & aging. 16:139-141
Insulin resistance (IR) may play a role in most pathogenic processes that promote the development of Late Onset Alzheimer Disease (LOAD). This study was designed to determine the interaction between inhibition of both butyrylcholinesterase (BuChE) an
Publikováno v:
American journal of Alzheimer's disease and other dementias. 29(8)
Objective: Rivastigmine is commonly used for the treatment of Alzheimer’s disease (AD). All cholinesterase inhibitors, including rivastigmine, may cause cardiac side effects. The aim of this study is to compare the electrocardiographic (ECG) and hy
Objective: Cholinesterase inhibitors (ChEIs) are widely used for the treatment of Alzheimer’s disease (AD); however, their cholinergic side effects on the cardiovascular system are still unclear. In this study, we aimed to examine the side effects
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::13d9eeb1f3d2b540bdfaf958df18d1c0
https://avesis.deu.edu.tr/publication/details/7669111a-9a9b-4070-b523-748b4822deb0/oai
https://avesis.deu.edu.tr/publication/details/7669111a-9a9b-4070-b523-748b4822deb0/oai
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.